Kevin Tan - Net Worth and Insider Trading
Kevin Tan Net Worth
The estimated net worth of Kevin Tan is at least $62,463 dollars as of 2024-06-21. Kevin Tan is the CFO & Treasurer of Solid Biosciences Inc and owns about 9,308 shares of Solid Biosciences Inc (SLDB) stock worth over $58,640. Kevin Tan is also the CFO of Cartesian Therapeutics Inc and owns about 167 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $3,823. Details can be seen in Kevin Tan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin Tan has not made any transactions after 2024-01-09 and currently still holds the listed stock(s).
Transaction Summary of Kevin Tan
Kevin Tan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin Tan owns 2 companies in total, including Cartesian Therapeutics Inc (RNAC) , and Solid Biosciences Inc (SLDB) .
Click here to see the complete history of Kevin Tan’s form 4 insider trades.
Insider Ownership Summary of Kevin Tan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2021-12-02 | Chief Financial Officer |
| SLDB | Solid Biosciences Inc | 2024-01-09 | CFO & Treasurer |
Kevin Tan Latest Holdings Summary
Kevin Tan currently owns a total of 2 stocks. Among these stocks, Kevin Tan owns 9,308 shares of Solid Biosciences Inc (SLDB) as of January 9, 2024, with a value of $58,640 and a weighting of 93.88%. Kevin Tan also owns 167 shares of Cartesian Therapeutics Inc (RNAC) as of December 2, 2021, with a value of $3,823 and a weighting of 6.12%.
Latest Holdings of Kevin Tan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc | 2024-01-09 | 9,308 | 6.30 | 58,640 |
| RNAC | Cartesian Therapeutics Inc | 2021-12-02 | 167 | 22.89 | 3,823 |
Holding Weightings of Kevin Tan
Kevin Tan Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin Tan has made a total of 1 transactions in Solid Biosciences Inc (SLDB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Solid Biosciences Inc is the sale of 3,935 shares on January 9, 2024, which brought Kevin Tan around $32,267.
According to the SEC Form 4 filings, Kevin Tan has made a total of 1 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 167 shares on December 2, 2021, which cost Kevin Tan around $15,150.
Insider Trading History of Kevin Tan
- 1
Kevin Tan Trading Performance
GuruFocus tracks the stock performance after each of Kevin Tan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Tan is -40.46%. GuruFocus also compares Kevin Tan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Tan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin Tan's insider trading performs compared to the benchmark.
Performance of Kevin Tan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.24 | | | | | |
| Relative Return to S&P 500(%) | 3.11 | | | | | |
Kevin Tan Ownership Network
Kevin Tan Owned Company Details
What does Cartesian Therapeutics Inc do?
Who are the key executives at Cartesian Therapeutics Inc?
Kevin Tan is the Chief Financial Officer of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Medical Officer Peter G Traber , director & President & CEO Carsten Brunn , and Chief Scientific Officer Takashi Kei Kishimoto .
Cartesian Therapeutics Inc (RNAC) Insider Trades Summary
Over the past 18 months, Kevin Tan made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,223,316 shares made by Timothy A Springer , a net sale of 44,002 shares made by Carsten Brunn , and a net sale of 12,349 shares made by Peter G Traber .
In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,531 shares of Cartesian Therapeutics Inc (RNAC) were sold and 40,777 shares were bought by its insiders, resulting in a net purchase of 38,247 shares.
Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cartesian Therapeutics Inc Insider Transactions
Kevin Tan Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin Tan. You might contact Kevin Tan via mailing address: 20 Hickory Road, Wellesley Ma 02482.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
